MoonLake Immunotherapeutics
MLTX
MLTX
43 hedge funds and large institutions have $111M invested in MoonLake Immunotherapeutics in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$788K | |
| 2 | +$622K | |
| 3 | +$320K | |
| 4 |
D.E. Shaw & Co
New York
|
+$168K |
| 5 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
+$149K |
Top Sellers
| 1 | -$518K | |
| 2 | -$513K | |
| 3 | -$327K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$320K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$100K |